Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose … – BioSpace

“These promising findings continue to validate CELZ-201-DDT as a potential breakthrough, non-opioid therapy for chronic back pain,” said Timothy …
Source: back pain